Cormorant Asset Management portfolio
67 tracked investments, 11 on the map, $3.1B raised across the mapped portfolio.
- Praxis Precision MedicinesSeries C
- Neurona TherapeuticsSeries F
- Stoke Therapeutics
- JENAVALVE TECHNOLOGYSeries C
- Artiva Biotherapeutics
- BiVACORSeries B
- Element ScienceSeries C
- AnaptysBioPost-IPO Equity
- ADARx Pharmaceuticals
- Dicerna Pharmaceuticals
- REGENXBIO
Also in the portfolio
- BioAge Labs
- enGene
- Terremoto Biosciences
- BlossomHill Therapeutics
- Vigil Neuroscience
- Biomea Fusion
- Latigo Biotherapeutics
- Fore Biotherapeutics
- Tyra Biosciences
- MOMA Therapeutics
- nChroma Bio
- Innovent Biologics
- Verve Therapeutics
- BBOT
- AltruBio
- Enliven Therapeutics
- Antares Therapeutics
- Centessa Pharmaceuticals
- Zai Lab
- GondolaBio
- Stratus Therapeutics
- Replimune Group
- Beam Therapeutics
- Bigfoot Biomedical
- Ardelyx
- connectRN
- Ventus Therapeutics
- Myra Vision
- KALA BIO
- Strata Oncology
- Cibus
- ALX Oncology
- Ambrx
- Tioga Cardiovascular
- Pliant Therapeutics
- Rain Oncology
- Autolus
- Pharvaris
- Kiniksa Pharmaceuticals
- Atreca
- FORMA Therapeutics
- Akouos
- VYNE Therapeutics
- Jounce Therapeutics
- Eidos Therapeutics
- Gelesis
- ContraFect
- Longboard Pharmaceuticals
- Clearside Biomedical
- Proteostasis Therapeutics
- Turning Point Therapeutics
- Atea Pharmaceuticals
- Viela Bio
- MyoKardia